Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
NeoProgen, a US-based biotech spinout of University of Maryland, Baltimore, completed a $1.5m seed round on Wednesday backed by the institution’s Maryland Momentum Fund and tech transfer office UM Ventures, as well as University of Maryland, Baltimore and Tedco. NeoProgen is working on a stem cell-based therapy for patients suffering from a heart attack or advanced heart failure. The cells used by the spinout have shown, in preclinical studies, to be significantly more effective in regenerating muscle tissue than comparable…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
